Across 28 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by 조인선, Directeur Exécutif. Officer active across 2 companies, notably 인바이오. Aggregated, 46 filings have been published. History available since 12 January 2026. The latest transaction was filed on 27 March 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Cho In-sun is the Executive Director at InBio. He is responsible for strategic direction and overseeing operations, aiming to promote innovation and growth within the company.